Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade

被引：0

作者：

Douglas B. Fox

Richard Y. Ebright

Xin Hong

Hunter C. Russell

Hongshan Guo

Thomas J. LaSalle

Ben S. Wittner

Nicolas Poux

Joanna A. Vuille

Mehmet Toner

Nir Hacohen

Genevieve M. Boland

Debattama R. Sen

Ryan J. Sullivan

Shyamala Maheswaran

Daniel A. Haber

机构：

[1] Massachusetts General Hospital Cancer Center and Harvard Medical School,Center for Engineering in Medicine

[2] Broad Institute of Harvard and MIT,Department of Surgery

[3] Massachusetts General Hospital and Harvard Medical School,Department of Medicine

[4] Shriners Hospitals for Children,Department of Biochemistry, School of Medicine and Key University Laboratory of Metabolism and Health of Guangdong

[5] Massachusetts General Hospital and Harvard Medical School,Liangzhu Laboratory

[6] Massachusetts General Hospital and Harvard Medical School,undefined

[7] Howard Hughes Medical Institute,undefined

[8] Southern University of Science and Technology,undefined

[9] Zhejiang University Medical Center,undefined

来源：

npj Precision Oncology | / 7卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Immune checkpoint blockade (ICB) has demonstrated efficacy in patients with melanoma, but many exhibit poor responses. Using single cell RNA sequencing of melanoma patient-derived circulating tumor cells (CTCs) and functional characterization using mouse melanoma models, we show that the KEAP1/NRF2 pathway modulates sensitivity to ICB, independently of tumorigenesis. The NRF2 negative regulator, KEAP1, shows intrinsic variation in expression, leading to tumor heterogeneity and subclonal resistance.

引用

共 50 条

[1] Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Fox, Douglas B.
Ebright, Richard Y.
Hong, Xin
Russell, Hunter C.
Guo, Hongshan
LaSalle, Thomas J.
Wittner, Ben S.
Poux, Nicolas
Vuille, Joanna A.
Toner, Mehmet
Hacohen, Nir
Boland, Genevieve M.
Sen, Debattama R.
Sullivan, Ryan J.
Maheswaran, Shyamala
Haber, Daniel A.
[J]. NPJ PRECISION ONCOLOGY, 2023, 7 (01)
[2] KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Zavitsanou, Anastasia -Maria
Pillai, Ray
Hao, Yuan
Wu, Warren L.
Bartnicki, Eric
Karakousi, Triantafyllia
Rajalingam, Sahith
Herrera, Alberto
Karatza, Angeliki
Rashidfarrokhi, Ali
Solis, Sabrina
Ciampricotti, Metamia
Yeaton, Anna H.
Ivanova, Ellie
Wohlhieter, Corrin A.
Buus, Terkild B.
Hayashi, Makiko
Karadal-Ferrena, Burcu
Pass, Harvey I.
Poirier, John T.
Rudin, Charles M.
Wong, Kwok-Kin
Moreira, Andre L.
Khanna, Kamal M.
Tsirigos, Aristotelis
Papagiannakopoulos, Thales
Koralov, Sergei B.
[J]. CELL REPORTS, 2023, 42 (11):
[3] Molecular patterns of resistance to immune checkpoint blockade in melanoma
Lauss, Martin
Phung, Bengt
Borch, Troels Holz
Harbst, Katja
Kaminska, Kamila
Ebbesson, Anna
Hedenfalk, Ingrid
Yuan, Joan
Nielsen, Kari
Ingvar, Christian
Carneiro, Ana
Isaksson, Karolin
Pietras, Kristian
Svane, Inge Marie
Donia, Marco
Jonsson, Goran
[J]. NATURE COMMUNICATIONS, 2024, 15 (01)
[4] The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Lim, Su Yin
Shklovskaya, Elena
Lee, Jenny H.
Pedersen, Bernadette
Stewart, Ashleigh
Ming, Zizhen
Irvine, Mal
Shivalingam, Brindha
Saw, Robyn P. M.
Menzies, Alexander M.
Carlino, Matteo S.
Scolyer, Richard A.
Long, Georgina V.
Rizos, Helen
[J]. NATURE COMMUNICATIONS, 2023, 14 (01)
[5] The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Su Yin Lim
Elena Shklovskaya
Jenny H. Lee
Bernadette Pedersen
Ashleigh Stewart
Zizhen Ming
Mal Irvine
Brindha Shivalingam
Robyn P. M. Saw
Alexander M. Menzies
Matteo S. Carlino
Richard A. Scolyer
Georgina V. Long
Helen Rizos
[J]. Nature Communications, 14
[6] ACQUIRED RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE BY PHENOTYPIC PLASTICITY OF MELANOMA
Robitschek, Emily
Mehta, Arnav
Lin, Jia-Ren
Frederick, Dennie
Shi, Alvin
Larque, Ana
Miao, Benchun
Raghavan, Rumya
Sharova, Tatyana
Shin, John
Kellis, Manolis
Hacohen, Nir
Flaherty, Keith
Boland, Genevieve
Chebib, Ivan
Liu, David
Sullivan, Ryan
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A955 - A955
[7] Downregulation of Keap1 Confers Features of a Fasted Metabolic State
Knatko, Elena V.
Tatham, Michael H.
Zhang, Ying
Castro, Cecilia
Higgins, Maureen
Naidu, Sharadha Dayalan
Leonardi, Chiara
de la Vega, Laureano
Honda, Tadashi
Griffin, Julian L.
Hay, Ronald T.
Dinkova-Kostova, Albena T.
[J]. ISCIENCE, 2020, 23 (10)
[8] MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma
de Azevedo, Ricardo A.
Shoshan, Einav
Whang, Shanzhi
Markel, Gal
Jaiswal, Ashvin R.
Liu, Arthur
Curran, Michael A.
Travassos, Luiz R.
Bar-Eli, Menashe
[J]. ONCOIMMUNOLOGY, 2020, 9 (01):
[9] Spatiotemporal analysis of metastatic melanoma reveals mechanisms of resistance to immune checkpoint blockade
Wei, Shiyou
Lee, Jinho
Labrie, Marilyne
Betts, Courtney
Liu, Lunxu
Coussens, Lisa
Herlyn, Meenhard
Boland, Genevieve
Mills, Gordon
Zhang, Gao
[J]. CANCER RESEARCH, 2023, 83 (07)
[10] Immune Checkpoint Blockade in Melanoma - Earlier is Better?
Urbonas, Vincas
Dulskas, Audrius
Baltruskeviciene, Edita
Dabkeviciene, Daiva
[J]. ACTA MEDICA LITUANICA, 2024, 31 (01) : 195 - 200

← 1 2 3 4 5 →